REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients

REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients

Background: Reducing the dose of biological therapy (BT) when patients with immune-mediated arthritis achieve a sustained therapeutic goal may help to decrease costs for national health services and reduce the risk of serious infection. However, there is little information about whether such a decis...

Full description

Bibliographic Details
Main Authors: Isidoro González-Álvaro, Antonio J. Blasco, Pablo Lázaro, Carlos Sánchez-Piedra, Raquel Almodovar, Javier Bachiller-Corral, Alejandro Balsa, Rafael Caliz, Gloria Candelas, Cristina Fernández-Carballido, Angel García-Aparicio, Blanca García-Magallón, Rosario García-Vicuña, Antonio Gómez-Centeno, Ana M. Ortiz, Raimon Sanmartí, Jesús Sanz, Beatriz Tejera
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Heliyon
Subjects:
Pharmaceutical science
Evidence-based medicine
Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844017310150

Internet

http://www.sciencedirect.com/science/article/pii/S2405844017310150

Similar Items